Back Menu
id опорной категории = 2
id текущей категории = 2
id родительской категории = 1News

News

HSCI Announces h1 2017 Consolidated Results Under IFRS 29.08.2017

Moscow – 29 August, 2017.   PJSC “HSCI” – The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies, today announced its reviewed consolidated interim results for the first  half of 2017 in accordance with the International…

Read More
Change in Shareholding Structure of HSCI 14.01.2014

Moscow – 14 January 2014 OJSC HSCI – The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies specializing in cell-based, gene and post-genome technologies, today announces a change in the company’s shareholding structure. Artur Isaev,…

Read More